{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:22:58Z","timestamp":1788870178487,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":3111,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"UCL Hospitals NIHR Biomedical Research Center."}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1111\/jth.12538","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T13:36:58Z","timestamp":1393249018000},"page":"736-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Platelet\u2010reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta\u2010analysis"],"prefix":"10.1016","volume":"12","author":[{"given":"P.P.","family":"Wisman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.W.","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.L.","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12538_bb0010","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12538_bb0015","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMra1011670","article-title":"The hemostatic system as a modulator of atherosclerosis","volume":"364","author":"Borissoff","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12538_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Antithrombotic Trialists' Collaboration Collaborative meta\u2010analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/jth.12538_bb0025","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2007.11.057","article-title":"Meta\u2010analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events","volume":"101","author":"Bowry","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.12538_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-6-9","article-title":"Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies","volume":"6","author":"Whiting","year":"2006","journal-title":"BMC Med Res Methodol"},{"issue":"Suppl. 1","key":"10.1111\/jth.12538_bb0035","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter\u2010Society Consensus for the Management of Peripheral Arterial Disease (TASC\u00a0II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1111\/jth.12538_bb0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ahj.2010.06.004","article-title":"Prognostic significance of high on\u2010clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta\u2010analysis","volume":"160","author":"Aradi","year":"2010","journal-title":"Am Heart J"},{"key":"10.1111\/jth.12538_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u2018resistance\u2019 and risk of cardiovascular morbidity: systematic review and meta\u2010analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/jth.12538_bb0050","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrcardio.2011.111","article-title":"The pharmacogenetics of antiplatelet agents: towards personalized therapy?","volume":"8","author":"Ahmad","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1111\/jth.12538_bb0055","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.amjcard.2009.07.015","article-title":"Relation of body mass index to high on\u2010treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention","volume":"104","author":"Bonello\u2010Palot","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.12538_bb0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pharmthera.2011.01.011","article-title":"Aspirin resistance: effect of clinical, biochemical and genetic factors","volume":"130","author":"Fitzgerald","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1111\/jth.12538_bb0065","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1111\/j.1538-7836.2010.04049.x","article-title":"Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta\u2010analysis","volume":"8","author":"Siller\u2010Matula","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12538_bb0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1055\/s-0037-1617137","article-title":"Platelet monitoring for PCI: which test is the one to choose?","volume":"29","author":"Capodanno","year":"2009","journal-title":"Hamostaseologie"},{"key":"10.1111\/jth.12538_bb0075","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1538-7836.2008.02897.x","article-title":"Use of the PFA\u2010100 closure time to predict cardiovascular events in aspirin\u2010treated cardiovascular patients: a systematic review and meta\u2010analysis","volume":"6","author":"Reny","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12538_bb0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/jth.12538_bb0085","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1538-7836.2010.04017.x","article-title":"High on\u2010aspirin platelet reactivity as measured with aggregation\u2010based, cyclooxygenase\u20101 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events","volume":"8","author":"Breet","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12538_bb0090","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/hrt.2010.220491","article-title":"High on\u2010treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention","volume":"97","author":"Breet","year":"2011","journal-title":"Heart"},{"key":"10.1111\/jth.12538_bb0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1755-5922.2010.00259.x","article-title":"Microembolic signals and aspirin resistance in patients with carotid stenosis","volume":"30","author":"Dawson","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1111\/jth.12538_bb0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/13685538.2012.666584","article-title":"The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease","volume":"15","author":"Cao","year":"2012","journal-title":"Aging Male"},{"key":"10.1111\/jth.12538_bb0105","first-page":"335","article-title":"Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events","volume":"48","author":"Gengo","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12538_bb0110","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1160\/TH08-06-0374","article-title":"Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function","volume":"100","author":"Gori","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12538_bb0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1160\/TH10-01-0007","article-title":"High on\u2010treatment platelet reactivity by more than one agonist predicts 12\u2010month follow\u2010up cardiovascular death and non\u2010fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting","volume":"104","author":"Marcucci","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12538_bb0120","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1161\/CIRCULATIONAHA.111.085464","volume":"125","author":"Reny","year":"2012","journal-title":"Circulation"},{"key":"10.1111\/jth.12538_bb0125","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"10.1111\/jth.12538_bb0130","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1160\/TH07-04-0296","article-title":"ADP\u2010induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non\u2010ST elevation acute coronary syndrome","volume":"98","author":"Frere","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12538_bb0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/09537100802351065","article-title":"Platelet reactivity to adenosine diphosphate and long\u2010term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target","volume":"19","author":"Gurbel","year":"2008","journal-title":"Platelets"},{"key":"10.1111\/jth.12538_bb0140","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-0037-1613462","article-title":"Prevalence of clopidogrel non\u2010responders among patients with stable angina pectoris scheduled for elective coronary stent placement","volume":"89","author":"Muller","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12538_bb0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1538-7836.2009.03699.x","article-title":"Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator\u2010stimulated phosphoprotein phosphorylation assay","volume":"8","author":"Siller\u2010Matula","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12538_bb0150","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2006.10.050","article-title":"Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?","volume":"49","author":"Bliden","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12538_bb0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ahj.2006.10.040","article-title":"Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review","volume":"153","author":"Hovens","year":"2007","journal-title":"Am Heart J"},{"key":"10.1111\/jth.12538_bb0160","first-page":"293","article-title":"Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?","volume":"147","author":"Cotter","year":"2004","journal-title":"Am Heart J"},{"key":"10.1111\/jth.12538_bb0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1741-7015-9-3","article-title":"Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance \u2013 the BOchum CLopidogrel and Aspirin Plan (BOCLA\u2010Plan) to improve antiplatelet therapy","volume":"9","author":"Neubauer","year":"2011","journal-title":"BMC Med"},{"key":"10.1111\/jth.12538_bb0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/09537100701206824","article-title":"Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients","volume":"18","author":"Dichiara","year":"2007","journal-title":"Platelets"},{"key":"10.1111\/jth.12538_bb0175","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.2337\/db07-0707","article-title":"The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin\u2010induced platelet effect (ASPECT) study","volume":"56","author":"DiChiara","year":"2007","journal-title":"Diabetes"},{"key":"10.1111\/jth.12538_bb0180","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.STR.0000151362.65339.f9","article-title":"Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure?","volume":"36","author":"Gonzalez\u2010Conejero","year":"2005","journal-title":"Stroke"},{"key":"10.1111\/jth.12538_bb0185","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","article-title":"Platelet function monitoring in patients with coronary artery disease","volume":"50","author":"Gurbel","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12538_bb0190","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.athoracsur.2006.08.002","article-title":"Dose\u2010related efficacy of aspirin after coronary surgery in patients with Pl(A2) polymorphism (NCT00262275)","volume":"83","author":"Lim","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.12538_bb0195","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1160\/TH05-10-0653","article-title":"Dose\u2010 and time\u2010dependent antiplatelet effects of aspirin","volume":"95","author":"Perneby","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12538_bb0200","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.thromres.2006.04.004","article-title":"Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in\u00a0vitro effect of aspirin","volume":"119","author":"Takahashi","year":"2007","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12538_bb0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjcard.2006.07.058","article-title":"Partial inhibition of platelet thromboxane\u00a0A2 synthesis by aspirin is associated with myonecrosis in patients with ST\u2010segment elevation myocardial infarction","volume":"99","author":"Valles","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.12538_bb0210","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jacc.2009.08.039","article-title":"Treatment of aspirin\u2010resistant patients with omega\u20103 fatty acids versus aspirin dose escalation","volume":"55","author":"Lev","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12538_bb0215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-150-6-200903170-00006","article-title":"Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding","volume":"150","author":"Steinhubl","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12538_bb0220","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12538_bb0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-642-29423-5_3","article-title":"Platelet signaling","volume":"210","author":"Stalker","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1111\/jth.12538_bb0230","first-page":"9","article-title":"A randomized pilot trial for aggressive therapeutic approaches in aspirin\u2010resistant patients undergoing percutaneous coronary intervention","volume":"23","author":"El\u2010Atat","year":"2011","journal-title":"J Invasive Cardiol"},{"key":"10.1111\/jth.12538_bb0235","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/CIRCULATIONAHA.108.833236","volume":"119","author":"Valgimigli","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/jth.12538_bb0240","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jacc.2008.12.025","volume":"53","author":"Jeong","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12538_bb0245","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jcin.2008.09.004","article-title":"Clopidogrel 150\u00a0mg\/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP\u201002 (Vasodilator\u2010Stimulated Phosphoprotein\u201002) randomized study","volume":"1","author":"Aleil","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1111\/jth.12538_bb0250","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcin.2010.12.011","article-title":"Prasugrel overcomes high on\u2010clopidogrel platelet reactivity post\u2010stenting more effectively than high\u2010dose (150\u2010mg) clopidogrel: the importance of CYP2C19*2 genotyping","volume":"4","author":"Alexopoulos","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1111\/jth.12538_bb0255","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1111\/j.1538-7836.2011.04531.x","article-title":"Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on\u2010treatment platelet reactivity","volume":"9","author":"Alexopoulos","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12538_bb0260","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.jacc.2010.07.004","volume":"56","author":"Bonello","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12538_bb0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijcard.2011.04.001","article-title":"A high maintenance dose increases the inhibitory response to clopidogrel in patients with high on\u2010treatment residual platelet reactivity","volume":"160","author":"Gremmel","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1111\/jth.12538_bb0270","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2012.03.050","article-title":"Ticagrelor versus prasugrel in acute coronary syndrome patients with high on\u2010clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study","volume":"60","author":"Alexopoulos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12538_bb0275","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ahj.2011.07.026","article-title":"Prasugrel overcomes high on\u2010clopidogrel platelet reactivity in chronic coronary artery disease patients more effectively than high dose (150\u00a0mg) clopidogrel","volume":"162","author":"Alexopoulos","year":"2011","journal-title":"Am Heart J"},{"key":"10.1111\/jth.12538_bb0280","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2007.12.044","article-title":"Adjusted clopidogrel loading doses according to vasodilator\u2010stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study","volume":"51","author":"Bonello","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12538_bb0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.amjcard.2008.08.048","article-title":"Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis","volume":"103","author":"Bonello","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.12538_bb0290","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/clc.20884","article-title":"Modifying clopidogrel maintenance doses according to vasodilator\u2010stimulated phosphoprotein phosphorylation index improves clinical outcome in patients with clopidogrel resistance","volume":"34","author":"Wang","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1111\/jth.12538_bb0295","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard\u2010 vs high\u2010dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"10.1111\/jth.12538_bb0300","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jcin.2008.08.018","article-title":"Glycoprotein\u00a0IIb\/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study","volume":"1","author":"Cuisset","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1111\/jth.12538_bb0305","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11239-012-0684-z","article-title":"Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention","volume":"34","author":"Hazarbasanov","year":"2012","journal-title":"J Thromb Thrombolysis"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12538","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12538","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622039289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622039289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12538\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:07:31Z","timestamp":1761534451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622039289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1538783622039289"],"URL":"https:\/\/doi.org\/10.1111\/jth.12538","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet\u2010reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta\u2010analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}